Charged nanoparticles delivery to the eye using hydrogel iontophoresis

Journal of Controlled Release

Volumn 126, Issue 2, 2008, Pages 156-161

  Eljarrat Binstock, Esther ^a   Orucov, Faik ^b   Aldouby, Yanir ^a   Frucht Pery, Joseph ^b   Domb, Abraham J ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Eye; Fluorescence; Hydrogel; Iontophoresis; Nanoparticles

Indexed keywords

FLUORESCENCE; HYDROGELS; NANOPARTICLES; POLYACRYLATES; TISSUE;

HYDROGEL IONTOPHORESIS; OCULAR IONTOPHORESIS; OCULAR THERAPEUTIC PATHWAY; POSTERIOR OCULAR TISSUES;

DRUG DELIVERY;

NANOPARTICLE; POLYACRYLIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CORNEA; ELECTRIC CURRENT; EYE; FLUORESCENCE; HYDROGEL; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SCLERA; SUSPENSION;

ANIMALS; DRUG DELIVERY SYSTEMS; EYE; HYDROGELS; IONTOPHORESIS; MALE; NANOPARTICLES; PARTICLE SIZE; RABBITS;

EID: 38749127952     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2007.11.016     Document Type: Article

References (39)

1. Ding S.L. Recent developments in ophthalmic drug delivery. Pharm. Sci. Technol. Today 1 8 (1998) 328-335
2. Kothuri M.K., Pinnamaneni S., Das N.G., et al. Microparticles and nanoparticles in ocular drug delivery. In: Mitra A.K. (Ed). Ophthalmic drug delivery systems vol. 130 (2003), Marcel Dekker, Inc., NY 437-466
3. Eljarrat-Binstock E., and Domb A.J. Nanoparticles in ocular drug delivery. In: Domb A.J., Tabata Y., Ravi Kumar M.N.V., and Farber S. (Eds). Nanoparticles for pharmaceutical applications (2007), American Scientific Publishers, California 367-376
4. J. Kreuter, Nanoparticles as bioadhesive ocular drug delivery systems, In: V.M. Lenaerts, R. Gurny (Eds.), Bioadhesive Drug Delivery Systems, Chapter 11, CRC Press, Boca Raton, Florida, 1990, pp. 203-212.
5. Gurny R., Boye T., and Ibrahim H. Ocular therapy with nanoparticulate systems for controlled drug delivery. J. Control. Release 2 (1985) 353-361
6. Diepold R.W., Kreuter J., Himber J., et al. Comparison of different models for the testing of pilocarpine eyedrops using conventional eyedrops as a novel depot formulation (nanoparticles). Graefe Arch. Clin. Exp. Ophthalmol. 227 (1989) 188-193
7. Zimmer A.K., Chetoni P., Saettone M.F., et al. Evaluation of Pilocarpine-Loaded Albumin Particles as Controlled Drug-Delivery Systems for the Eye.2. Coadministration with Bioadhesive and Viscous Polymers. J. Control. Release 33 1 (1995) 31-46
8. Vandervoort J., and Ludwig A. Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur. J. Pharm. Biopharm. 57 2 (2004) 251-261
9. Marchal-Heussler L., Fessi H., Devissaguet J.P., et al. Colloidal drug delivery systems for the eye. A comparison of the efficacy of three different polymers: polyisobutylcyanoacrylate, polylactic-coglycolic acid, poly-epsilon-caprolactone. Pharm. Sci. 2 1 (1992) 98-104
10. Merodio M., Irache J.M., Valamanesh F., et al. Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats. Biomaterials 23 7 (2002) 1587-1594
11. Losa C., Calvo P., Castro E., et al. Improvement of Ocular Penetration of Amikacin Sulfate by Association to Poly(Butylcyanoacrylate) Nanoparticles. J. Pharm. Pharmacol. 43 8 (1991) 548-552
12. Alonso M.J., Losu C., Seijo B., et al. Ner ophthalmic drug release systems: formulation and ocular disposition of amikacin loaded nanoparticles. 5th Int Conf Pharm Tech vol. 1 (1989) 77-83
13. Pignatello R., Bucolo C., Ferrara P., et al. Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur. J. Pharm. Sci. 16 (2002) 53-61
14. Calvo P., Alonso M.J., Vila-Jato J.L., et al. Improved ocular bioavailability of indomethacin by novel ocular drug carriers. J. Pharm. Pharmacol. 48 (1996) 1147-1152
15. Bucolo C., Maltese A., Maugeri F., et al. Eudragit RL100 nanoparticle system for the ophthalmic delivery of cloricromene. J. Pharm. Pharmacol. 56 7 (2004) 841-846
16. Calvo P., Sanchez A., Martinez J., et al. Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A. Pharm. Res. 13 2 (1996) 311-315
17. Le Bourlais C., Chevanne F., Turlin B., et al. Effect of cyclosporin A formulations on bovine corneal absorption: ex-vivo study. J. Microencapsul. 14 4 (1997) 457-467
18. De Kozak Y., Andrieux K., Villarroya H., et al. Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis. Eur. J. Immunol. 34 12 (2004) 3702-3712
19. Eljarrat-Binstock E., and Domb A.J. Iontophoresis: A non-invasive ocular drug delivery. J. Control. Release 110 3 (2006) 479-489
20. Behar-Cohen F.F., El Aouni A., Gautier S., et al. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: Influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp. Eye Res. 74 1 (2002) 51-59
21. Eljarrat-Binstock E., Domb A.J., Orucov F., et al. Methotrexate delivery to the eye using transscleral hydrogel iontophoresis. Curr. Eye Res. 32 7 (2007) 639-646
22. Eljarrat-Binstock E., Raiskup F., Stepensky D., et al. Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis. Investig. Ophthalmol. Vis. Sci. 45 8 (2004) 2543-2548
23. Halhal M., Renard G., Courtois Y., et al. Iontophoresis: from the lab to the bed side. Exp. Eye Res. 78 3 (2004) 751-757
24. Parkinson T.M., Ferguson E., Febbraro S., et al. Tolerance of ocular iontophoresis in healthy volunteers. J. Ocular Pharmacol. Ther. 19 2 (2003) 145-151
25. Vollmer D.L., Szlek M.A., Kolb K., et al. In vivo transscleral iontophoresis of amikacin to rabbit eyes. J. Ocular Pharmacol. Ther. 18 6 (2002) 549-558
26. Eljarrat-Binstock E., Raiskup F., Frucht-Pery J., et al. Hydrogel probe for iontophoresis drug delivery to the eye. J. Biomater. Sci., Polym. Ed. 15 4 (2004) 397-413
27. Andrieu-Soler C., Doat M., Halhal M., et al. Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis. Mol. Vis. 12 124 (2006) 1098-1107
28. Asahara T., Shinomiya K., Naito T., et al. Induction of gene into the rabbit eye by iontophoresis: Preliminary report. Jpn. J. Ophthalmol. 45 1 (2001) 31-39
29. Berdugo M., Valamanesh F., Andrieu C., et al. Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev. 13 2 (2003) 107-114
30. Eliyahu H., Joseph A., Schillemans J.P., et al. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically. Biomaterials 28 14 (2007) 2339-2349
31. Bejjani R., BenEzra D., Cohen H., et al. Nanoparticles for gene delivery to retinal pigment epithelial cells. Mol. Vis. 11 14 (2005) 124-132
32. Bejjani R.A., Behar-Cohen F., Benezra D., et al. Polymeric nanoparticles for drug delivery to the posterior segment of the eye. Chimia 59 6 (2005) 344-347
33. Bourges J.L., Gautier S.E., Delie F., et al. Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles. Investig. Ophthalmol. Vis. Sci. 44 8 (2003) 3562-3569
34. Calvo P., Vila-Jato J.L., and Alonso M.J. Evaluation of cationic polymer-coated nanocapsules as ocular drug carriers. Int. J. Pharm. 153 (1997) 41-50
35. De Campos A.M., Diebold Y., Carvalho E.L.S., et al. Chitosan nanoparticles as new ocular drug delivery systems: in vitro stability, in vivo fate, and cellular toxicity. Pharm. Res. 21 5 (2004) 803-810
36. Mainardes R.M., Urban M.C.C., Cinto P.O., et al. Colloidal carriers for ophthalmic drug delivery. Curr. Drug Targets 6 3 (2005) 363-371
37. Calvo P., Thomas C., Alonso M.J., et al. Study of the mechanism of interaction of poly(e-caprolactone) nanocapsules with the cornea by confocal laser scanning microscopy. Int. J. Pharm. 55 (1994) 283-291
38. Lehr C.M., Bouwstra J.R., Schacht E.H., et al. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 78 (1992) 43-48
39. De Campos A.M., Sanchez A., Gref R., et al. The effect of PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci 20 (2003) 73-81